abnormalreturns
Tadas Viskanta, Founder and Editor of Abnormal Returns. Author of Abnormal Returns: Winning Strategies from the Frontlines of the Investment Blogosphere.
StockTwitsIR
Deliver real-time, compliant and trackable IR updates and corporate news to your social networks and leading financial portals with StockTwits IR.
Ligand is a biopharmaceutical company with a business model of developing or acquiring royalty revenue-generating assets and coupling them to a lean corporate cost structure to produce sustained profitability.
Erika Luib
Investor Relations
eluib@ligand.com
11085 North Torrey Pines Road, Suite 300
La Jolla, CA, 92037
United States of America